BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

357 related articles for article (PubMed ID: 15346340)

  • 1. Induction of human T cell-mediated immune responses after primary and secondary smallpox vaccination.
    Kennedy JS; Frey SE; Yan L; Rothman AL; Cruz J; Newman FK; Orphin L; Belshe RB; Ennis FA
    J Infect Dis; 2004 Oct; 190(7):1286-94. PubMed ID: 15346340
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Primary induction of human CD8+ cytotoxic T lymphocytes and interferon-gamma-producing T cells after smallpox vaccination.
    Ennis FA; Cruz J; Demkowicz WE; Rothman AL; McClain DJ
    J Infect Dis; 2002 Jun; 185(11):1657-9. PubMed ID: 12023773
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The persistence of humoral and cellular immunities more than three decades after smallpox vaccination.
    Kim SH; Yeo SG; Park KH; Bang JW; Kim HB; Kim NJ; Jee Y; Cho H; Oh MD; Choe KW
    Clin Microbiol Infect; 2007 Jan; 13(1):91-3. PubMed ID: 17184294
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Real time PCR for the assessment of CD8+ T cellular immune response after prophylactic vaccinia vaccination.
    Trojan A; Rajeswaran R; Montemurro M; Mütsch M; Steffen R
    J Clin Virol; 2007 Sep; 40(1):80-3. PubMed ID: 17644471
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immune responses to vaccinia and influenza elicited during primary versus recent or distant secondary smallpox vaccination of adults.
    Treanor J; Wu H; Liang H; Topham DJ
    Vaccine; 2006 Nov; 24(47-48):6913-23. PubMed ID: 17014939
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhanced immunogenicity and protective effect conferred by vaccination with combinations of modified vaccinia virus Ankara and licensed smallpox vaccine Dryvax in a mouse model.
    Meseda CA; Garcia AD; Kumar A; Mayer AE; Manischewitz J; King LR; Golding H; Merchlinsky M; Weir JP
    Virology; 2005 Sep; 339(2):164-75. PubMed ID: 15993917
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Distinct time effects of vaccination on long-term proliferative and IFN-gamma-producing T cell memory to smallpox in humans.
    Combadiere B; Boissonnas A; Carcelain G; Lefranc E; Samri A; Bricaire F; Debre P; Autran B
    J Exp Med; 2004 Jun; 199(11):1585-93. PubMed ID: 15184506
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dose-related effects of smallpox vaccine.
    Frey SE; Newman FK; Cruz J; Shelton WB; Tennant JM; Polach T; Rothman AL; Kennedy JS; Wolff M; Belshe RB; Ennis FA
    N Engl J Med; 2002 Apr; 346(17):1275-80. PubMed ID: 11923489
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical and immunological responses to undiluted and diluted smallpox vaccine with vaccinia virus of Lister strain.
    Hsieh SM; Chen SY; Sheu GC; Hung MN; Chou WH; Chang SC; Hsu KH
    Vaccine; 2006 Jan; 24(4):510-5. PubMed ID: 16139395
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Postexposure immunization with modified vaccinia virus Ankara or conventional Lister vaccine provides solid protection in a murine model of human smallpox.
    Paran N; Suezer Y; Lustig S; Israely T; Schwantes A; Melamed S; Katz L; Preuss T; Hanschmann KM; Kalinke U; Erez N; Levin R; Velan B; Löwer J; Shafferman A; Sutter G
    J Infect Dis; 2009 Jan; 199(1):39-48. PubMed ID: 19012492
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Evaluation of residual immune response against human pox virus before and after revaccination in healthy volunteers].
    Bricaire F; Combadière B; Rouleau E; Bossi P; Garin D; Lebrun-Vignes B; Autran B
    Bull Acad Natl Med; 2006; 190(4-5):1035-46; discussion 1046-9. PubMed ID: 17195626
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical responses to smallpox vaccine in vaccinia-naive and previously vaccinated populations: undiluted and diluted Lancy-Vaxina vaccine in a single-blind, randomized, prospective trial.
    Kim SH; Yeo SG; Jang HC; Park WB; Lee CS; Lee KD; Kim HB; Kim NJ; Kim YT; Jee Y; Cho H; Oh MD; Choe KW
    J Infect Dis; 2005 Sep; 192(6):1066-70. PubMed ID: 16107961
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cell-mediated immune responses to smallpox vaccination.
    Kim SH; Yeo SG; Cho JH; Kim HB; Kim NJ; Oh MD; Choe KW; Jee Y; Cho H
    Clin Vaccine Immunol; 2006 Oct; 13(10):1172-4. PubMed ID: 17028221
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Age distribution for T cell reactivity to vaccinia virus in a healthy population.
    Hsieh SM; Pan SC; Chen SY; Huang PF; Chang SC
    Clin Infect Dis; 2004 Jan; 38(1):86-9. PubMed ID: 14679452
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical and immune responses after revaccination of israeli adults with the Lister strain of vaccinia virus.
    Orr N; Forman M; Marcus H; Lustig S; Paran N; Grotto I; Klement E; Yehezkelli Y; Robin G; Reuveny S; Shafferman A; Cohen D; ;
    J Infect Dis; 2004 Oct; 190(7):1295-302. PubMed ID: 15346341
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Comparison of the kinesis of immune responses in mice vaccinated by different kinds of recombinant hepatitis B vaccines].
    Hu ZY; He P; Fang X; Qiu SH; Liang ZL; Li HM; Zhuang H
    Zhonghua Liu Xing Bing Xue Za Zhi; 2008 Aug; 29(8):810-4. PubMed ID: 19103120
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of vaccinia CD8+ T-cell epitopes conserved among vaccinia and variola viruses restricted by common MHC class I molecules, HLA-A2 or HLA-B7.
    Terajima M; Cruz J; Leporati AM; Demkowicz WE; Kennedy JS; Ennis FA
    Hum Immunol; 2006 Jul; 67(7):512-20. PubMed ID: 16829305
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of the safety and immunogenicity of ACAM1000, ACAM2000 and Dryvax in healthy vaccinia-naive adults.
    Frey SE; Newman FK; Kennedy JS; Ennis F; Abate G; Hoft DF; Monath TP
    Vaccine; 2009 Mar; 27(10):1637-44. PubMed ID: 19071184
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunization with recombinant modified vaccinia Ankara (rMVA) constructs encoding the HA or NP gene protects ponies from equine influenza virus challenge.
    Breathnach CC; Clark HJ; Clark RC; Olsen CW; Townsend HG; Lunn DP
    Vaccine; 2006 Feb; 24(8):1180-90. PubMed ID: 16194586
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dose-dependent neutralizing-antibody responses to vaccinia.
    Belshe RB; Newman FK; Frey SE; Couch RB; Treanor JJ; Tacket CO; Yan L
    J Infect Dis; 2004 Feb; 189(3):493-7. PubMed ID: 14745707
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.